Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2004
02/05/2004US20040023996 Methods and compositions utilizing quinazolinones
02/05/2004US20040023968 Phthalazinone derivatives
02/05/2004US20040023966 Agricultural/ horticultural fungicides containing said derivatives as the active ingredients.
02/05/2004US20040023945 Cyclic amp-specific phosphodiesterase inhibitors
02/05/2004US20040023805 Substituted phenyluracils
02/05/2004DE10234876A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl
02/05/2004DE10234058A1 Neue substituierte Benzoesäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted benzamides, their preparation and their use as medicaments
02/05/2004DE10148618A1 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments
02/05/2004CA2494102A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
02/05/2004CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004CA2493309A1 Site-specific labelling of proteins using cyanine dye reporters
02/05/2004CA2492305A1 Aryl substituted benzimidazoles and their use as sodium channel blockers
02/04/2004EP1386915A1 Azole compounds, process for preparation of the same and use thereof
02/04/2004EP1386913A1 Pyrrole derivative
02/04/2004EP1386912A1 Cyclic amidine derivative
02/04/2004EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
02/04/2004EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors
02/04/2004EP1385845A1 N-aroyl cyclic amines
02/04/2004EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
02/04/2004EP1385840A1 Sulfonamides
02/04/2004EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor
02/04/2004EP1385833A1 Triazinyl amide derivatives as angiogenesis inhibitors
02/04/2004EP1385832A2 Production of tertiary amines by reductive amination
02/04/2004EP1385828A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents
02/04/2004EP1385823A1 Novel guanidino compounds
02/04/2004EP1385507A1 Sulfonamides
02/04/2004EP0684816B1 5-ht2 receptor antagonists for treating venous conditions
02/04/2004CN1473161A Pyrazole compounds as protein kinase inhibitors
02/04/2004CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents
02/04/2004CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands
02/04/2004CN1473154A Phthalazinone derivatives
02/04/2004CN1473153A Hetero-anellated ortho-aminophenols
02/03/2004US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds
02/03/2004US6686372 Selective β3 adrenergic agonists
02/03/2004US6686369 α-hydrdroxylic acid derivatives, their production and use
02/03/2004US6686368 Inhibitors of factor Xa
02/03/2004US6686362 Indolinone derivatives
02/03/2004US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
02/03/2004US6686350 Cell adhesion inhibitors
02/03/2004CA2092510C Crystalline forms of endo-2,3-dihydro-n-(8-methyl-8-azabicyclo-[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3 ethyl-2,3-dihydro-n-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamide hydrochloride monohydrate
01/2004
01/29/2004WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
01/29/2004WO2004009585A2 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors
01/29/2004WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
01/29/2004WO2004009562A1 Substituted triazine kinase inhibitors
01/29/2004WO2004009548A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
01/29/2004WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
01/29/2004WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
01/29/2004WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt
01/29/2004WO2004009036A2 Compounds compositions and methods
01/29/2004WO2004008859A1 Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them
01/29/2004WO2004008837A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
01/29/2004WO2003072572A8 Beta3-adrenergic receptor agonists
01/29/2004WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use
01/29/2004WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/29/2004US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor
01/29/2004US20040019190 Thrombopoietin mimetics
01/29/2004US20040019093 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
01/29/2004US20040019092 Non-peptide somatostatin receptor ligands
01/29/2004US20040019091 Cholecystokinin receptor agonists; antiobesity agents
01/29/2004US20040019083 Amino acid derivatives; antineoplastic agents
01/29/2004US20040019058 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
01/29/2004US20040019050 Selective NPY (Y5) antagonists (triazines)
01/29/2004US20040019049 Substituted quinazolinone compounds
01/29/2004US20040019046 Phenylacetamido-pyrazole derivatives and their use as antitumor agents
01/29/2004US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents
01/29/2004US20040019038 Compounds useful as anti-inflammatory agents
01/29/2004US20040019037 E.g.,((5-(2,4-Diaminopyrimidin-6-yl)pentanoyl)-(N-methyl)amino )-3-(6-meth-oxypyridin-3-yl)-propanoic acid, inhibition of bone resorption, restenosis, angiogenesis inhibitors, antiarthritic, -tumor, -carcinogenic agents; antidiabetic
01/29/2004US20040019033 Mandelic acid derivatives and their use as throbin inhibitors
01/29/2004US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
01/29/2004US20040018986 Viricide against hepatitis virus
01/29/2004US20040018942 Herbicides; controlling weeds
01/29/2004US20040018941 Applying to plants; synergistic mixture
01/29/2004US20040018192 Integrin expression inhibitors
01/29/2004DE10239612A1 Verfahren und Verbindungen zur Beeinflussung der Raumstruktur von GNB-Proteinen Methods and compounds for influencing the spatial structure of proteins GNB
01/29/2004CA2493721A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
01/29/2004CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof
01/29/2004CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
01/29/2004CA2492224A1 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutics
01/29/2004CA2492217A1 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
01/29/2004CA2491248A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
01/28/2004EP1384717A2 Tetrazolylphenylboronic acid intermediates for the synthesis of A II receptor antagonists
01/28/2004EP1384712A1 Derivatives of N-((quinolinyl)oxy)-phenyl)-urea and N-((quinazolinyl)oxy)-phenyl)-urea with antitumor activity
01/28/2004EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors
01/28/2004EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
01/28/2004EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
01/28/2004EP1383743A2 Dual inhibitors of pde 7 and pde 4
01/28/2004EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
01/28/2004EP1268479B1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands
01/28/2004EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
01/28/2004CN1471535A Tricyclic derivatives of indole with antiangiogenic activity
01/28/2004CN1471525A Triazole derivatives and pharmaceutical compounds comprising them
01/28/2004CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
01/28/2004CN1471394A Tripeptidyl peptidase inhibitors
01/28/2004CN1136217C 4-aryloxindoles as inhibitor of JNK protein kinases
01/28/2004CN1136198C Novel benzyl pyrimidines
01/27/2004US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives
01/27/2004US6683191 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction
01/27/2004US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
01/27/2004US6683176 Intermediates for and synthesis of 3-methylene cephams
01/27/2004US6683106 Reduced side effects; efficacy